Risk factors for long-term graft loss in kidney transplantation: Experience of a Mexican single-center

Revista de Investigacion Clinica

Volumn 54, Issue 6, 2002, Pages 492-496

  González, Francisco ^a,b   Cueto Manzano, Alfonso M ^a,b   Rojas, Enrique ^a,b   Rosales, Guillermo ^a,b   Gómez, Benjamín ^a,b   Flores, Antonio ^a,b   Chávez, Salvador ^a,b   Camarena, J Luis ^a,b   Paredes, Graciela ^a,b   Sandoval, Mario ^a,b   Valdespino, Carlos ^a,b   Gutiérrez, Florencio ^a,b   Monteón, Francisco ^a,b   Martínez, Hétor Ramón ^a,b   Cortés Sanabria, Laura ^a,b  

^a Children's Hospital   (Mexico)

^b HOSPITAL DE ESPECIALIDADES   (Mexico)

Author keywords

Graft loss; Latin American; Mexican; Renal transplantation; Risk factors; Survival

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; METHYLPREDNISOLONE; OKT 3; PREDNISONE;

ACUTE GRAFT REJECTION; ADOLESCENT; ADULT; AGED; ARTICLE; CADAVER KIDNEY; CHRONIC GRAFT REJECTION; CONTROLLED STUDY; FEMALE; GRAFT SURVIVAL; HAPLOTYPE; HLA MATCHING; HUMAN; KAPLAN MEIER METHOD; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MEXICO; MORTALITY; MULTIVARIATE ANALYSIS; RISK ASSESSMENT; RISK FACTOR; SCHOOL CHILD; SIDE EFFECT; SOUTH AND CENTRAL AMERICA; STATISTICAL MODEL; SURVIVAL TIME;

ADOLESCENT; ADULT; AGED; CHILD; COHORT STUDIES; FEMALE; GRAFT SURVIVAL; HUMANS; KIDNEY TRANSPLANTATION; MALE; MEXICO; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TIME FACTORS;

EID: 0036881098     PISSN: 00348376     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Merion RM, White DJG, Thiru S, Evans DB, Calne RY. Cyclosporine: five years' experience in cadaveric renal transplantation. N Engl J Med 1984; 310: 148-54.
2. Ortho Multicenter Transplant Study Group. A randomized clinical trial of OKT3 monoclonal antibody for acute rejection of cadaveric renal transplants. N Engl J Med 1985; 313: 337-42.
3. Sollinger HW. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. Transplantation 1995; 60: 225-32.
4. Pirsch JD, Miller J, Deierhoi MH, Vicenti F, Filo RS. A comparison of tracolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. Transplantation 1997; 63: 977-83.
5. Thiel G, Bock A, Spondlin M et al. Long-term benefits and risks of cyclosporin A (Sandimmun): an analysis at 10 years. Transplant Proc 1994; 26: 2493-8.
6. Hariharan S, Johnson CP, Bresnahan BA, Taranto SE, McIntosh MJ, Stablein D. Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med 2000; 342: 605-12.
7. Santiago Delpín EA, Duro García V. Latin American Organ Transplant Registry. Tansplant Proc 1999; 31: 2232-4.
8. Santiago-Delpín EA, Duro-García V. The tenth report of the Latin American Transplant Registry. Tansplant Proc 1999; 31: 2837-8.
9. Melchor JL, Gracida C. Kidney transplantation with living donors: better long-term survival. Transplant Proc 1999; 31: 2294-5.
10. Bordes-Aznar J, Peña JC, Herrera-Acosta J, Tamayo J, Elías-Dib J, Gabilondo F, Feria G, Kasep J, Chávez-Peón F, Dib-Kuri A, Mancilla E, Alberú J. Twenty-four-year experience in kidney transplantation at one single institution in Mexico City. Transplant Proc 1992; 24: 1794-5.
11. Opelz G. Factors influencing kidney graft survival in Latin America. Transplant Proc 1999; 31: 2951-4.
12. Takemoto SK, Cho YW, Gjertson DW. Transplant risks. In: Cecka M, Terasaki PI (eds). Clinical Transplants 1999, UCLA Immunogenetics Center, Los Angeles 2000; pp 325-40.
13. Ciancio G, Contreras N, Esquenazi V, Gomez C, Gharagozloo H, Burke GW, Garcia-Morales R, Olson L, Rosen A, Colona J, Roth D, Strauss J, Ricordi C, Miller J. Kidney transplantation at the University of Miami. In: Cecka M, Terasaki PI (eds). Clinical Transplants 1999, UCLA Immunogenetics Center, Los Angeles 2000; pp 159-72.
14. Vathsala A, Thye Woo K. Renal transplantation in cyclosporine-treated recipients at the Singapore General Hospital. In: Cecka M, Terasaki PI (eds). Clinical Transplants 1999, UCLA Immunogenetics Center, Los Angeles 2000; pp 189-97.
15. Gjertson DW. Determinants of long-term survival of adult kidney transplants: a 1999 UNOS update. In: Cecka M, Terasaki PI (eds). Clinical Transplants 1999, UCLA Immunogenetics Center, Los Angeles 2000; pp 341-52.